RecruitingNCT07645872
Clinical Data Collection of Patients Treated With High Intensity Focused Ultrasound (HIFU) by the Focal One for Their Prostate Cancer.
Sponsor
EDAP TMS S.A.
Enrollment
3,000 participants
Start Date
Feb 1, 2023
Study Type
OBSERVATIONAL
Conditions
Summary
The aim of the registry is to gather real-life data to evaluate the clinical performance and safety of medical devices in patients who have been treated with HIFU thank to the Focal One device for their prostate cancer.
Eligibility
Sex: MALE
Inclusion Criteria2
- Being treated for prostate cancer with the Focal One device
- Patient does not object and consent* to the collection of clinical data in the registry
Exclusion Criteria2
- Patient deprived of liberty following a judicial or administrative decision
- Patient under guardianship or curatorship * if applicable according to local regulation
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(5)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07645872
Related Trials
A Study of Tinengotinib (TT-00420) in Combination With Standard Treatments in People With Prostate Cancer
NCT0645791912 locations
Phase I Study of 225Ac-J591 Plus 177Lu-PSMA Small Molecule for Progressive Metastatic Castration Resistant Prostate Cancer
NCT048869862 locations
Presurgical Phase II Study of Talazoparib in Combination With Enzalutamide in Prostate Cancer
NCT058731921 location
Water Vapor Ablation for Prostate Cancer: Long-Term Registry
NCT074550582 locations
Aggressive Disease Treatment Patterns and CtDNA HRR evaluatiON in High-volume metastatiC hORmone-sensitive Prostate Cancer in Russian FeDeration
NCT0705257822 locations